{"id":40179,"date":"2026-10-14T12:05:45","date_gmt":"2026-10-14T12:05:45","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=40179"},"modified":"2026-10-14T12:05:45","modified_gmt":"2026-10-14T12:05:45","slug":"rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/","title":{"rendered":"\u30ea\u30ba\u30e0\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u3001\u8996\u5e8a\u4e0b\u90e8\u6027\u80a5\u6e80\u6cbb\u7642\u85ac\u300cIM CIVREE\u300d\u3092\u65e5\u672c\u3067\u767a\u58f2\u3057\u305f"},"content":{"rendered":"

\u30ea\u30ba\u30e0\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u306f\u73fe\u5728\u3001\u65e5\u672c\u3067\u300cIM CIVREE\u300d\u3092\u8ca9\u58f2\u3057\u3066\u3044\u308b\u3002\u3053\u306e\u85ac\u306b\u306f\u30bb\u30c8\u30e1\u30e9\u30ce\u30c1\u30c9\u304c\u542b\u307e\u308c\u3066\u304a\u308a\u3001\u5f8c\u5929\u6027\u80a5\u6e80\u306e\u60a3\u8005\u306e\u6cbb\u7642\u306b\u5f79\u7acb\u3064\u3002 \u3053\u306e\u767a\u58f2\u304c\u5b9f\u73fe\u3057\u305f\u306e\u306f\u3001\u540c\u85ac\u304c\u65e5\u672c\u306e\u56fd\u6c11\u5065\u5eb7\u4fdd\u967a\u306e\u85ac\u4fa1\u53ce\u8f09\u30ea\u30b9\u30c8\u306b\u8ffd\u52a0\u3055\u308c\u305f\u305f\u3081\u3060\u3002IM CIVREE\u306f\u73fe\u5728\u3001\u3053\u306e\u7a2e\u306e\u80a5\u6e80\u306b\u5bfe\u3059\u308b\u627f\u8a8d\u3055\u308c\u305f\u6cbb\u7642\u6cd5\u3068\u306a\u3063\u3066\u3044\u308b\u3002\u5f8c\u5929\u6027\u8996\u5e8a\u4e0b\u90e8\u6027\u80a5\u6e80\u306f\u3001\u7a7a\u8179\u611f\u3001\u30a8\u30cd\u30eb\u30ae\u30fc\u4ee3\u8b1d\u3001\u4f53\u91cd\u3092\u5236\u5fa1\u3059\u308b\u8133\u306e\u4e00\u90e8\u3067\u3042\u308b\u8996\u5e8a\u4e0b\u90e8\u304c\u640d\u50b7\u3092\u53d7\u3051\u305f\u5834\u5408\u306b\u767a\u75c7\u3059\u308b\u3053\u3068\u304c\u3042\u308b\u3002.<\/p>

\u3053\u306e\u767a\u58f2\u306f\u3001\u539a\u751f\u52b4\u50cd\u7701\u304c2026\u5e748\u6708\u306b\u540c\u85ac\u3092\u627f\u8a8d\u3057\u305f\u3053\u3068\u3092\u53d7\u3051\u3066\u884c\u308f\u308c\u305f\u3082\u306e\u3060\u3002\u30ea\u30ba\u30e0\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u793e\u306f\u3001\u65e5\u672c\u3067\u7d045,000\u4eba\u304b\u30898,000\u4eba\u304c\u5f8c\u5929\u6027\u80a5\u6e80\u3092\u60a3\u3063\u3066\u3044\u308b\u3068\u63a8\u5b9a\u3057\u3066\u3044\u308b\u3002\u540c\u793e\u306f\u3001\u3053\u306e\u75be\u60a3\u306b\u5bfe\u3059\u308b\u30bb\u30c8\u30e1\u30e9\u30ce\u30c1\u30c9\u306b\u3064\u3044\u3066\u3001\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u306e\u6307\u5b9a\u3082\u53d7\u3051\u3066\u3044\u305f\u3002.<\/p>

\u5e0c\u5c11\u306a\u30bf\u30a4\u30d7\u306e\u80a5\u6e80\u3078\u306e\u53d6\u308a\u7d44\u307f<\/h3>

\u5f8c\u5929\u6027\u80a5\u6e80\u306f\u3001\u901a\u5e38\u306e\u80a5\u6e80\u3068\u306f\u7570\u306a\u308b\u3002\u3053\u308c\u306f\u3001\u8996\u5e8a\u4e0b\u90e8\u304c\u640d\u50b7\u3057\u305f\u308a\u6a5f\u80fd\u969c\u5bb3\u3092\u8d77\u3053\u3057\u305f\u308a\u3057\u305f\u969b\u306b\u751f\u3058\u308b\u3053\u3068\u304c\u3042\u308b\u3002\u3053\u306e\u3088\u3046\u306a\u640d\u50b7\u306f\u3001\u8133\u816b\u760d\u3084\u305d\u306e\u9818\u57df\u306b\u5f71\u97ff\u3092\u53ca\u307c\u3059\u305d\u306e\u4ed6\u306e\u75be\u60a3\u306e\u6cbb\u7642\u5f8c\u306b\u751f\u3058\u308b\u3053\u3068\u304c\u591a\u3044\u3002.<\/p>

\u8996\u5e8a\u4e0b\u90e8\u304c\u640d\u50b7\u3059\u308b\u3068\u3001\u7a7a\u8179\u4fe1\u53f7\u3084\u4f53\u306e\u30a8\u30cd\u30eb\u30ae\u30fc\u6d88\u8cbb\u306b\u4e71\u308c\u304c\u751f\u3058\u308b\u3053\u3068\u304c\u3042\u308b\u3002\u305d\u306e\u7d50\u679c\u3001\u7a7a\u8179\u611f\u3084\u6025\u6fc0\u306a\u4f53\u91cd\u5897\u52a0\u304c\u8d77\u3053\u308b\u3002\u3053\u3046\u3057\u305f\u5909\u5316\u306b\u3088\u308a\u3001\u60a3\u8005\u304c\u4f53\u91cd\u3092\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u3057\u7d9a\u3051\u308b\u3053\u3068\u306f\u975e\u5e38\u306b\u56f0\u96e3\u306b\u306a\u308b\u3002.<\/p>

IM CIVREE\u306f\u3001\u30e1\u30e9\u30ce\u30b3\u30eb\u30c1\u30f34\u53d7\u5bb9\u4f53\uff08MC4R\uff09\u7d4c\u8def\u3092\u6d3b\u6027\u5316\u3059\u308b\u3053\u3068\u3067\u4f5c\u7528\u3059\u308b\u3002\u3053\u306e\u7d4c\u8def\u306f\u3001\u7a7a\u8179\u611f\u3084\u30a8\u30cd\u30eb\u30ae\u30fc\u30d0\u30e9\u30f3\u30b9\u306e\u8abf\u7bc0\u306b\u95a2\u4e0e\u3057\u3066\u3044\u308b\u3002IM CIVREE\u306b\u542b\u307e\u308c\u308b\u30bb\u30c8\u30e1\u30e9\u30ce\u30c1\u30c9\u306f\u3001\u3053\u306e\u7d4c\u8def\u3092\u6a19\u7684\u3068\u3057\u3001\u5f8c\u5929\u6027\u8996\u5e8a\u4e0b\u90e8\u6027\u80a5\u6e80\u3092\u5f15\u304d\u8d77\u3053\u3059\u554f\u984c\u3092\u6539\u5584\u3059\u308b\u3002.<\/p>

\u65e5\u672c\u3067\u306e\u767a\u58f2\u306b\u3088\u308a\u3001\u3053\u308c\u307e\u3067\u3053\u306e\u75be\u60a3\u306b\u5bfe\u3057\u3066\u627f\u8a8d\u3055\u308c\u305f\u85ac\u304c\u306a\u304b\u3063\u305f\u60a3\u8005\u306b\u3068\u3063\u3066\u3001\u9078\u629e\u80a2\u304c\u5e83\u304c\u308b\u3002\u3068\u306f\u3044\u3048\u3001\u60a3\u8005\u304cIM CIVREE\u3092\u4f7f\u7528\u3067\u304d\u308b\u304b\u3069\u3046\u304b\u3001\u307e\u305f\u305d\u306e\u52b9\u679c\u304c\u3069\u306e\u7a0b\u5ea6\u3042\u308b\u304b\u306f\u3001\u533b\u5b66\u7684\u8a55\u4fa1\u304a\u3088\u3073\u5f53\u8a72\u85ac\u5264\u306e\u516c\u5f0f\u306a\u51e6\u65b9\u60c5\u5831\u306b\u4f9d\u5b58\u3059\u308b\u3002.<\/p>

\u7b2c3\u76f8\u81e8\u5e8a\u8a66\u9a13\u304c\u65e5\u672c\u3067\u306e\u627f\u8a8d\u3092\u88cf\u4ed8\u3051\u305f<\/h3>

\u65e5\u672c\u3067\u306e\u627f\u8a8d\u306f\u3001\u7b2c3\u76f8TRANSCEND\u8a66\u9a13\u306e\u7d50\u679c\u306b\u3088\u3063\u3066\u88cf\u4ed8\u3051\u3089\u308c\u305f\u3002\u3053\u306e\u56fd\u969b\u5171\u540c\u8a66\u9a13\u306b\u306f\u3001\u5f8c\u5929\u6027\u80a5\u6e80\u306e\u60a3\u8005142\u540d\u304c\u53c2\u52a0\u3057\u305f\u3002\u3053\u306e\u30b0\u30eb\u30fc\u30d7\u306b\u306f\u3001\u65e5\u672c\u304b\u3089\u306e\u60a3\u800512\u540d\u306b\u52a0\u3048\u3001120\u540d\u306e\u4e3b\u8981\u30b3\u30db\u30fc\u30c8\u4ee5\u5916\u306e\u53c2\u52a0\u800510\u540d\u304c\u542b\u307e\u308c\u3066\u3044\u305f\u3002.<\/p>

\u30ea\u30ba\u30e0\u793e\u306b\u3088\u308b\u3068\u3001\u3053\u306e\u7814\u7a76\u306f\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3092\u9054\u6210\u3057\u305f\u3002\u305d\u306e\u7d50\u679c\u3001\u4f53\u683c\u6307\u6570\uff08BMI\uff09\u306b\u304a\u3044\u3066\u3001\u30d7\u30e9\u30bb\u30dc\u5bfe\u6bd4\u306718.8%\u3068\u3044\u3046\u6709\u610f\u306a\u6e1b\u5c11\u304c\u793a\u3055\u308c\u305f\u3002\u3053\u308c\u306f\u3001\u6cbb\u7642\u7fa4\u306eBMI\u304c\u30d7\u30e9\u30bb\u30dc\u7fa4\u306b\u6bd4\u3079\u3066\u4f4e\u4e0b\u3057\u305f\u3053\u3068\u3092\u610f\u5473\u3059\u308b\u3002\u3053\u306e\u6570\u5024\u306f\u7fa4\u9593\u306e\u5dee\u3092\u8868\u3057\u3066\u3044\u308b\u3082\u306e\u3067\u3042\u308a\u3001\u3059\u3079\u3066\u306e\u60a3\u8005\u304c\u540c\u7a0b\u5ea6\u306e\u4f53\u91cd\u6e1b\u5c11\u3092\u793a\u3057\u305f\u308f\u3051\u3067\u306f\u306a\u3044\u3002.<\/p>

\u3053\u306e\u7d50\u679c\u306f\u3001\u3053\u306e\u6cbb\u7642\u6cd5\u304c\u5f8c\u5929\u6027\u8996\u5e8a\u4e0b\u90e8\u6027\u80a5\u6e80\u306e\u60a3\u8005\u306b\u6709\u52b9\u3067\u3042\u308b\u3053\u3068\u3092\u88cf\u4ed8\u3051\u3066\u3044\u308b\u3002 \u305d\u306e\u5229\u70b9\u3068\u30ea\u30b9\u30af\u306e\u4e21\u65b9\u3092\u7406\u89e3\u3059\u308b\u305f\u3081\u306b\u306f\u3001\u4f9d\u7136\u3068\u3057\u3066\u81e8\u5e8a\u7814\u7a76\u304c\u9375\u3068\u306a\u308b\u3002\u3053\u306e\u85ac\u304c\u65e5\u672c\u3067\u5229\u7528\u53ef\u80fd\u306b\u306a\u308b\u306b\u3064\u308c\u3001\u533b\u5e2b\u3084\u533b\u7642\u5f93\u4e8b\u8005\u306f\u3001\u305d\u306e\u6700\u9069\u306a\u4f7f\u7528\u65b9\u6cd5\u3092\u8a55\u4fa1\u3057\u306a\u3051\u308c\u3070\u306a\u3089\u306a\u3044\u3002\u5f7c\u3089\u306f\u3001\u627f\u8a8d\u3055\u308c\u305f\u88fd\u54c1\u60c5\u5831\u306b\u5f93\u3044\u3001\u60a3\u8005\u3092\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3059\u308b\u3068\u3068\u3082\u306b\u3001\u4e00\u4eba\u3072\u3068\u308a\u306e\u75c5\u6b74\u3084\u72b6\u614b\u3092\u8003\u616e\u306b\u5165\u308c\u308b\u5fc5\u8981\u304c\u3042\u308b\u3002.<\/p>

\u56fd\u6c11\u5065\u5eb7\u4fdd\u967a\u3078\u306e\u63b2\u8f09\u306b\u3088\u308a\u3001\u5e02\u8ca9\u304c\u53ef\u80fd\u306b\u306a\u308b<\/h3>

IMCIVREE\u304c\u65e5\u672c\u306e\u56fd\u6c11\u5065\u5eb7\u4fdd\u967a\u306e\u85ac\u4fa1\u30ea\u30b9\u30c8\u306b\u8ffd\u52a0\u3055\u308c\u305f\u3053\u3068\u3092\u53d7\u3051\u3001\u540c\u85ac\u306e\u5546\u696d\u8ca9\u58f2\u304c\u958b\u59cb\u3055\u308c\u305f\u3002\u3053\u306e\u63aa\u7f6e\u306b\u3088\u308a\u3001\u540c\u85ac\u306e\u516c\u7684\u533b\u7642\u4fdd\u967a\u5236\u5ea6\u306b\u304a\u3051\u308b\u5b9a\u4fa1\u304c\u78ba\u5b9a\u3057\u3001\u901a\u5e38\u306e\u533b\u7642\u63d0\u4f9b\u4f53\u5236\u3078\u306e\u5c0e\u5165\u304c\u4fc3\u9032\u3055\u308c\u308b\u3002.<\/p>

\u3053\u306e\u52d5\u304d\u306f\u3001\u5e0c\u5c11\u75be\u60a3\u306e\u6cbb\u7642\u85ac\u3092\u60a3\u8005\u306e\u624b\u5143\u306b\u5c4a\u3051\u308b\u4e0a\u3067\u3001\u65e5\u672c\u306e\u898f\u5236\u3084\u4fdd\u967a\u511f\u9084\u306e\u30d7\u30ed\u30bb\u30b9\u304c\u3069\u306e\u3088\u3046\u306a\u5f79\u5272\u3092\u679c\u305f\u3057\u3066\u3044\u308b\u304b\u3092\u793a\u3057\u3066\u3044\u308b\u3002\u8ca9\u58f2\u627f\u8a8d\u3068\u306f\u3001\u305d\u306e\u533b\u85ac\u54c1\u304c\u627f\u8a8d\u3055\u308c\u305f\u9069\u5fdc\u75c7\u306b\u5bfe\u3057\u3066\u8ca9\u58f2\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308b\u3053\u3068\u3092\u610f\u5473\u3059\u308b\u3002\u4fa1\u683c\u8a2d\u5b9a\u3068\u4fdd\u967a\u511f\u9084\u3082\u540c\u69d8\u306b\u91cd\u8981\u3067\u3042\u308a\u3001\u305d\u308c\u3089\u304c\u60a3\u8005\u304c\u5b9f\u969b\u306b\u305d\u306e\u533b\u85ac\u54c1\u3092\u5165\u624b\u3067\u304d\u308b\u304b\u3069\u3046\u304b\u3092\u5de6\u53f3\u3059\u308b\u304b\u3089\u3060\u3002.<\/p>

\u30ea\u30ba\u30e0\u793e\u306f\u3001\u767a\u58f2\u306b\u5099\u3048\u3066\u65e5\u672c\u3067\u306e\u30c1\u30fc\u30e0\u3092\u62e1\u5145\u3057\u3066\u3044\u308b\u3068\u8ff0\u3079\u305f\u3002\u540c\u793e\u306e\u56fd\u969b\u4e8b\u696d\u306f\u3001\u5168\u56fd\u306e\u60a3\u8005\u3084\u533b\u7642\u5f93\u4e8b\u8005\u304c\u3053\u306e\u533b\u85ac\u54c1\u3092\u5229\u7528\u3067\u304d\u308b\u3088\u3046\u652f\u63f4\u3059\u308b\u53d6\u308a\u7d44\u307f\u3092\u652f\u3048\u308b\u3053\u3068\u306b\u306a\u308b\u3002.<\/p>

\u5b9f\u969b\u306b\u6cbb\u7642\u3092\u53d7\u3051\u308b\u60a3\u8005\u6570\u304c\u3069\u308c\u307b\u3069\u306b\u306a\u308b\u304b\u306f\u3001\u8a3a\u65ad\u3055\u308c\u308b\u60a3\u8005\u306e\u6570\u3001\u81e8\u5e8a\u57fa\u6e96\u3092\u6e80\u305f\u3057\u3066\u3044\u308b\u304b\u3069\u3046\u304b\u3001\u533b\u7642\u5f93\u4e8b\u8005\u304c\u3053\u306e\u75be\u60a3\u306b\u3064\u3044\u3066\u3069\u308c\u307b\u3069\u7406\u89e3\u3057\u3066\u3044\u308b\u304b\u3001\u305d\u3057\u3066\u305d\u306e\u85ac\u304c\u65e5\u672c\u306e\u533b\u7642\u5236\u5ea6\u306b\u3069\u308c\u307b\u3069\u9069\u5408\u3059\u308b\u304b\u306b\u3088\u3063\u3066\u6c7a\u307e\u308b\u3002 \u540c\u793e\u306f\u3001\u65e5\u672c\u3067\u3053\u306e\u75be\u60a3\u3092\u6301\u3064\u4eba\u306f5,000\u4eba\u304b\u30898,000\u4eba\u7a0b\u5ea6\u3068\u63a8\u5b9a\u3057\u3066\u3044\u308b\u3002\u3053\u306e\u6570\u5b57\u306f\u6f5c\u5728\u7684\u306a\u60a3\u8005\u6570\u3067\u3042\u308a\u3001\u5b9f\u969b\u306b\u6cbb\u7642\u3092\u53d7\u3051\u308b\u3068\u4e88\u60f3\u3055\u308c\u308b\u4eba\u6570\u3067\u306f\u306a\u3044\u3002.<\/p>

\u5e0c\u5c11\u75be\u60a3\u6cbb\u7642\u306b\u304a\u3051\u308b\u3055\u3089\u306a\u308b\u524d\u9032<\/h3>

\u65e5\u672c\u3067\u306e\u767a\u58f2\u306f\u3001\u30ea\u30ba\u30e0\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u304c\u5e0c\u5c11\u306a\u795e\u7d4c\u5185\u5206\u6ccc\u75be\u60a3\u306b\u6ce8\u529b\u3059\u308b\u53d6\u308a\u7d44\u307f\u306e\u4e00\u74b0\u3067\u3042\u308b\u3002\u540c\u793e\u306f\u3001\u7a7a\u8179\u611f\u3084\u4f53\u91cd\u3092\u5236\u5fa1\u3059\u308b\u7d4c\u8def\u306b\u7126\u70b9\u3092\u5f53\u3066\u305f\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u308b\u3002.<\/p>

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a SOLA Biosciences Japan\u3001ALS\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u5411\u3051\u306b60\u5104\u5186\u306e\u52a9\u6210\u91d1\u3092\u78ba\u4fdd\u3057\u305f<\/a><\/h4>

\u5f8c\u5929\u6027\u80a5\u6e80\u306e\u4eba\u3005\u306b\u3068\u3063\u3066\u3001\u627f\u8a8d\u3055\u308c\u305f\u6cbb\u7642\u6cd5\u306e\u767b\u5834\u306f\u3001\u4f53\u91cd\u306b\u95a2\u9023\u3059\u308b\u91cd\u5927\u304b\u3064\u9577\u671f\u7684\u306a\u554f\u984c\u3092\u3082\u305f\u3089\u3059\u3053\u306e\u75be\u60a3\u306b\u5bfe\u51e6\u3059\u308b\u305f\u3081\u306e\u65b0\u305f\u306a\u624b\u6bb5\u3068\u306a\u308b\u3002\u65e5\u672c\u306b\u304a\u3051\u308b\u3053\u306e\u6cbb\u7642\u6cd5\u306e\u52b9\u679c\u306f\u3001\u533b\u7642\u73fe\u5834\u3067\u306e\u904b\u7528\u72b6\u6cc1\u3084\u3001\u533b\u5e2b\u304c\u6cbb\u7642\u3092\u5fc5\u8981\u3068\u3059\u308b\u60a3\u8005\u3092\u3069\u308c\u3060\u3051\u7684\u78ba\u306b\u898b\u3064\u3051\u51fa\u305b\u308b\u304b\u306b\u304b\u304b\u3063\u3066\u3044\u308b\u3002.<\/p>

\u4eca\u56de\u306e\u767a\u58f2\u306f\u3001\u80a5\u6e80\u3092\u5358\u4e00\u306e\u554f\u984c\u3068\u3057\u3066\u6349\u3048\u308b\u306e\u3067\u306f\u306a\u304f\u3001\u75be\u60a3\u306e\u7279\u5b9a\u306e\u539f\u56e0\u306b\u5408\u308f\u305b\u3066\u958b\u767a\u3055\u308c\u305f\u6cbb\u7642\u6cd5\u3078\u3068\u5411\u304b\u3046\u533b\u7642\u306e\u50be\u5411\u3092\u793a\u3057\u3066\u3044\u308b\u3002\u660e\u78ba\u306b\u5b9a\u7fa9\u3055\u308c\u305f\u60a3\u8005\u7fa4\u3092\u5bfe\u8c61\u3068\u3057\u305f\u6a19\u7684\u6cbb\u7642\u85ac\u304c\u5229\u7528\u53ef\u80fd\u306b\u306a\u308b\u306b\u3064\u308c\u3001\u78ba\u56fa\u305f\u308b\u533b\u5b66\u7684\u6839\u62e0\u306b\u57fa\u3065\u3044\u305f\u9069\u5207\u306a\u8a3a\u65ad\u3092\u884c\u3044\u3001\u6cbb\u7642\u3078\u306e\u30a2\u30af\u30bb\u30b9\u3092\u78ba\u4fdd\u3059\u308b\u3053\u3068\u304c\u3001\u4eca\u5f8c\u3082\u6975\u3081\u3066\u91cd\u8981\u3067\u3042\u308a\u7d9a\u3051\u308b\u3060\u308d\u3046\u3002.<\/p>

IMCIVREE\u304c\u5229\u7528\u53ef\u80fd\u306b\u306a\u3063\u305f\u4eca\u3001\u65e5\u672c\u3067\u306f\u6b21\u306e\u6bb5\u968e\u3068\u3057\u3066\u3001\u533b\u7642\u73fe\u5834\u3067\u306e\u4f7f\u7528\u3092\u958b\u59cb\u3057\u3001\u60a3\u8005\u304c\u3053\u306e\u6cbb\u7642\u3092\u53d7\u3051\u305f\u969b\u306e\u7d4c\u904e\u3092\u7d99\u7d9a\u7684\u306b\u78ba\u8a8d\u3057\u3066\u3044\u304f\u3053\u3068\u306b\u306a\u308b\u3002.<\/p>","protected":false},"excerpt":{"rendered":"

Rhythm Pharmaceuticals is now selling IM CIVREE in Japan. The drug contains setmelanotide, which helps patients who have acquired obesity. The launch is possible because the medicine was added to Japan’s National Health Insurance price list. IM CIVREE is now the approved treatment for this type of obesity. Acquired hypothalamic obesity can happen when the hypothalamus, a part of the brain that controls hunger, energy and weight is damaged.The launch comes after the Ministry of Health Labour and Welfare approved the drug in August 2026. Rhythm Pharmaceuticals estimates that about 5,000 to 8,000 people in Japan have acquired obesity. Rhythm Pharmaceuticals had also earned orphan drug status for setmelanotide for […]<\/p>\n","protected":false},"author":7,"featured_media":40210,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,8098,182],"tags":[16308,16309,16310,314,16311],"ppma_author":[572],"class_list":["post-40179","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-news-articles","category-pharma","tag-drug-contains","tag-hypothalamic-obesity","tag-im-civree","tag-japan","tag-rhythm-pharmaceuticals"],"yoast_head":"\nRhythm Pharma Launches IMCIVREE in Japan<\/title>\n<meta name=\"description\" content=\"Rhythm Pharmaceuticals launches IMCIVREE in Japan, expanding access to treatment for acquired hypothalamic obesity.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rhythm Pharma Launches IMCIVREE in Japan\" \/>\n<meta property=\"og:description\" content=\"Rhythm Pharmaceuticals launches IMCIVREE in Japan, expanding access to treatment for acquired hypothalamic obesity.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-14T12:05:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/Rhythm-Pharmaceuticals-Announces-Commercial-Launch-of-IMCIVREE\u00ae-setmelanotide-in-Japan-for-Patients-with-Acquired-Hypothalamic-Obesity.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ea\u30ba\u30e0\u30fb\u30d5\u30a1\u30fc\u30de\u304c\u65e5\u672c\u3067\u300cIMCIVREE\u300d\u3092\u767a\u58f2\u3057\u305f","description":"\u30ea\u30ba\u30e0\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u306f\u3001\u65e5\u672c\u306b\u304a\u3044\u3066\u300cIMCIVREE\u300d\u3092\u767a\u58f2\u3057\u3001\u5f8c\u5929\u6027\u8996\u5e8a\u4e0b\u90e8\u6027\u80a5\u6e80\u306e\u6cbb\u7642\u3078\u306e\u30a2\u30af\u30bb\u30b9\u3092\u62e1\u5927\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/","og_locale":"ja_JP","og_type":"article","og_title":"Rhythm Pharma Launches IMCIVREE in Japan","og_description":"Rhythm Pharmaceuticals launches IMCIVREE in Japan, expanding access to treatment for acquired hypothalamic obesity.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/","og_site_name":"itbusinesstoday","article_published_time":"2026-10-14T12:05:45+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/Rhythm-Pharmaceuticals-Announces-Commercial-Launch-of-IMCIVREE\u00ae-setmelanotide-in-Japan-for-Patients-with-Acquired-Hypothalamic-Obesity.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"4\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Rhythm Pharmaceuticals Launches IM CIVREE in Japan for Hypothalamic Obesity","datePublished":"2026-10-14T12:05:45+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/"},"wordCount":836,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/Rhythm-Pharmaceuticals-Announces-Commercial-Launch-of-IMCIVREE\u00ae-setmelanotide-in-Japan-for-Patients-with-Acquired-Hypothalamic-Obesity.webp","keywords":["drug contains","Hypothalamic Obesity","IM CIVREE","Japan","Rhythm Pharmaceuticals"],"articleSection":["Health Tech","News Articles","Pharma"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/","name":"\u30ea\u30ba\u30e0\u30fb\u30d5\u30a1\u30fc\u30de\u304c\u65e5\u672c\u3067\u300cIMCIVREE\u300d\u3092\u767a\u58f2\u3057\u305f","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/Rhythm-Pharmaceuticals-Announces-Commercial-Launch-of-IMCIVREE\u00ae-setmelanotide-in-Japan-for-Patients-with-Acquired-Hypothalamic-Obesity.webp","datePublished":"2026-10-14T12:05:45+00:00","description":"\u30ea\u30ba\u30e0\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u306f\u3001\u65e5\u672c\u306b\u304a\u3044\u3066\u300cIMCIVREE\u300d\u3092\u767a\u58f2\u3057\u3001\u5f8c\u5929\u6027\u8996\u5e8a\u4e0b\u90e8\u6027\u80a5\u6e80\u306e\u6cbb\u7642\u3078\u306e\u30a2\u30af\u30bb\u30b9\u3092\u62e1\u5927\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/Rhythm-Pharmaceuticals-Announces-Commercial-Launch-of-IMCIVREE\u00ae-setmelanotide-in-Japan-for-Patients-with-Acquired-Hypothalamic-Obesity.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/10\/Rhythm-Pharmaceuticals-Announces-Commercial-Launch-of-IMCIVREE\u00ae-setmelanotide-in-Japan-for-Patients-with-Acquired-Hypothalamic-Obesity.webp","width":1200,"height":800,"caption":"Rhythm-Pharmaceuticals"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/rhythm-pharmaceuticals-launches-im-civree-in-japan-for-hypothalamic-obesity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Rhythm Pharmaceuticals Launches IM CIVREE in Japan for Hypothalamic Obesity"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/40179","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=40179"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/40179\/revisions"}],"predecessor-version":[{"id":40182,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/40179\/revisions\/40182"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/40210"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=40179"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=40179"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=40179"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=40179"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}